Biodexa Pharmaceuticals Files July 2025 6-K Report
Ticker: BDRX · Form: 6-K · Filed: Jul 15, 2025 · CIK: 1643918
| Field | Detail |
|---|---|
| Company | Biodexa Pharmaceuticals PLC (BDRX) |
| Form Type | 6-K |
| Filed Date | Jul 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, pharmaceuticals
TL;DR
Biodexa Pharma (BDRX) filed its July 6-K, standard update for investors.
AI Summary
Biodexa Pharmaceuticals Plc filed a Form 6-K on July 15, 2025, reporting for the month of July 2025. The company, formerly known as Midatech Pharma Plc, is based in Cardiff, United Kingdom, and operates in the pharmaceutical preparations industry. This filing is in accordance with Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Biodexa Pharmaceuticals Plc's ongoing operations and compliance as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain significant new financial or operational information that would typically alter risk.
Key Players & Entities
- Biodexa Pharmaceuticals Plc (company) — Filer of the report
- Midatech Pharma Plc (company) — Former name of the registrant
- July 15, 2025 (date) — Filing date
- 20250715 (date) — Conformed period of report
- 001-37652 (other) — SEC file number
- 1 Caspian Point, Caspian Way Cardiff, CF10 4DQ, United Kingdom (address) — Principal executive offices
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, used to furnish information which the issuer makes or is required to make public in its home country.
When was Biodexa Pharmaceuticals Plc previously known by another name?
Biodexa Pharmaceuticals Plc was formerly known as Midatech Pharma Plc, with a date of name change on June 2, 2015.
What is Biodexa Pharmaceuticals Plc's standard industrial classification?
Biodexa Pharmaceuticals Plc's standard industrial classification is Pharmaceutical Preparations [2834].
Where are Biodexa Pharmaceuticals Plc's principal executive offices located?
Biodexa Pharmaceuticals Plc's principal executive offices are located at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom.
Does Biodexa Pharmaceuticals Plc file annual reports under Form 20-F or 40-F?
Biodexa Pharmaceuticals Plc indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 15, 2025 regarding Biodexa Pharmaceuticals Plc (BDRX).